Balaxi Pharmaceuticals Q2 FY23 Earnings Results

Balaxi Pharmaceuticals Limited financial results presentation for Q2 FY23, highlighting performance as a branded, IPR-driven pharmaceutical company operating in frontier markets. The document includes corporate snapshot, financial highlights, and strategic roadmap for the company's growth initiatives.